What is the main business of Interforum Pharma?

The main business activity of Interforum Pharma focuses on wholesale of pharmaceutical goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on December 20, 2001.

Where is the headquarters located?

The headquarters is located at: Macieja Dębskiego 12, 30-499 Kraków.

What is the share capital?

The share capital of the company is PLN 204,000 (approx. $55,105).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What was the revenue?

In 2024, the company generated total revenue of $710,215.

Is the company profitable?

Yes, in 2024 the company was profitable, achieving a net profit of $108,012.

What is the main operating cost?

The largest operating cost category falls under materials and energy. This category amounted to $430,309 in 2024, representing 73% of all operating expenses.

Interforum Pharmasp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2001-12-20

Share capital

204 000,00 PLN

Activity description

Interforum Pharma is an international pharmaceutical company operating in Berlin and at the Port of Hamburg. It provides professional service, efficient order execution and carriage services.

Registered address

Macieja Dębskiego 12, 30-499 Kraków, Poland

Website

interforumpharma.com

Phone

Financials

The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue

This companyUSD 710.21kMedianUSD 873.84kAverageUSD 20.03m

Net profit

This companyUSD 108.01kMedianUSD 28.21kAverageUSD 815.54k

Operating costs

This companyUSD 588.82kMedianUSD 801.08kAverageUSD 18.78m

Assets

This companyUSD 914.75kMedianUSD 539.29kAverageUSD 10.66m

Industry

Bank accounts

Registered as a VAT taxpayer on 1995-05-31. Active

Bank Pekao SA
65 1240 1431 1111 0000 1045 4868
Bank Pekao SA
70 1240 1431 1978 0000 1045 4884

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

Authorized Representatives

Ewa Jolanta Sadowska — Management Board Member

Jan Mieczysław Żmuda — President

Manner of representation

Each member of the management board independently and individually.

Ownership

Owner	Shares	Share value	Stake
Ewa Jolanta Sadowska (73)	196	$26,472.18	48.0392%
Jan Mieczysław Żmuda (80)	212	$28,633.17	51.9608%

Beneficial owners

Person	Rights
Ewa Sadowska (73)	Shareholder of a limited liability company, 98000.0 PLN
Jan Żmuda (80)	Shareholder of a limited liability company, 106000.0 PLN

Competitors

Name	Revenue	Website
Imchexsp. z o.o.	$5,008,364.97	imchex.com
Manormsp. z o.o.	$4,632,182.01	manorm.pl
Polska Grupa Farmaceutycznasp. z o.o.	$3,192,376.31	pgflomza.pl
Flexhousesp. z o.o.	$2,717,612.10	flexhouse.pl
Farmbudsp. z o.o.	$2,476,637.88	farmbud.eu
PUBE Globalsp. z o.o.	$1,777,827.09	pubeglobal.com
Interimsp. z o.o.	$563,181.62	interim.com.pl
E-Distributionsp. z o.o.	$356,102.46	e-distribution.pl
Vorwarts Pharmasp. z o.o.	$210,138.62	vorwartspharma.pl
Pharmbiopolsp. z o.o.	$99,211.10	pharmbiopol.com

Change history

Date	Event
2012-10-19	Address change (J. Lea 202, 30 - 133, Kraków → Macieja Dębskiego 12, 30-499, Kraków)
2001-12-20	Entered in the register

FAQ

Last updated: 2026-04-03